Correlation Between OncoSec Medical and Virax Biolabs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OncoSec Medical and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoSec Medical and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoSec Medical and Virax Biolabs Group, you can compare the effects of market volatilities on OncoSec Medical and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoSec Medical with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoSec Medical and Virax Biolabs.

Diversification Opportunities for OncoSec Medical and Virax Biolabs

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between OncoSec and Virax is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding OncoSec Medical and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and OncoSec Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoSec Medical are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of OncoSec Medical i.e., OncoSec Medical and Virax Biolabs go up and down completely randomly.

Pair Corralation between OncoSec Medical and Virax Biolabs

If you would invest  168.00  in Virax Biolabs Group on October 22, 2024 and sell it today you would earn a total of  50.00  from holding Virax Biolabs Group or generate 29.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy1.61%
ValuesDaily Returns

OncoSec Medical  vs.  Virax Biolabs Group

 Performance 
       Timeline  
OncoSec Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Virax Biolabs Group 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.

OncoSec Medical and Virax Biolabs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OncoSec Medical and Virax Biolabs

The main advantage of trading using opposite OncoSec Medical and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoSec Medical position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.
The idea behind OncoSec Medical and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk